CLEVER LEAVES HOLDINGS INC (CLVR) Stock Price, Forecast & Analysis
NASDAQ:CLVR • CA1867602031
CLVR Key Statistics, Chart & Performance
The current stock price of CLVR is 3 USD. In the past month the price decreased by -26.74%. In the past year, price decreased by -60.1%.
CLVR Technical Analysis
CLVR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CLVR. CLVR may be in some trouble as it scores bad on both profitability and health.
CLVR Financial Highlights
Over the last trailing twelve months CLVR reported a non-GAAP Earnings per Share(EPS) of -11.4. The EPS increased by 78.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -57.31% | ||
| ROE | -73.94% | ||
| Debt/Equity | 0.03 |
CLVR Forecast & Estimates
6 analysts have analysed CLVR and the average price target is 24.48 USD. This implies a price increase of 716% is expected in the next year compared to the current price of 3.
For the next year, analysts expect an EPS growth of 29.03% and a revenue growth 50% for CLVR
CLVR Ownership
CLVR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 31.05 | 1.001T | ||
| JNJ | JOHNSON & JOHNSON | 21.14 | 592.302B | ||
| MRK | MERCK & CO. INC. | 22.9 | 307.324B | ||
| PFE | PFIZER INC | 9.04 | 153.855B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 10.12 | 124.69B | ||
| ZTS | ZOETIS INC | 18.73 | 55.434B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.75 | 26.247B | ||
| VTRS | VIATRIS INC | 6.35 | 18.371B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 25.23 | 12.297B | ||
| AXSM | AXSOME THERAPEUTICS INC | 207.52 | 8.81B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CLVR
Company Profile
Clever Leaves Holdings Inc is a CO-based company operating in Pharmaceuticals industry. The company employs 400 full-time employees The company went IPO on 2020-12-18. Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The firm's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. The company offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.
Company Info
CLEVER LEAVES HOLDINGS INC
Bodega 19-B Parque Industrial Tibitoc Ph, Tocancipa - Cundinamarca
Boca Raton FLORIDA 10017 CO
CEO: Kyle Detwiler
Employees: 400
Phone: 16468804382.0
CLEVER LEAVES HOLDINGS INC / CLVR FAQ
What does CLEVER LEAVES HOLDINGS INC do?
Clever Leaves Holdings Inc is a CO-based company operating in Pharmaceuticals industry. The company employs 400 full-time employees The company went IPO on 2020-12-18. Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The firm's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. The company offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.
Can you provide the latest stock price for CLEVER LEAVES HOLDINGS INC?
The current stock price of CLVR is 3 USD. The price increased by 42.18% in the last trading session.
What is the dividend status of CLEVER LEAVES HOLDINGS INC?
CLVR does not pay a dividend.
What is the ChartMill technical and fundamental rating of CLVR stock?
CLVR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is CLVR stock listed?
CLVR stock is listed on the Nasdaq exchange.
Can you provide the upcoming earnings date for CLEVER LEAVES HOLDINGS INC?
CLEVER LEAVES HOLDINGS INC (CLVR) will report earnings on 2024-08-12, after the market close.